Answers are grounded in this paper and cite their sources.
This review highlights the shared mechanisms and synergistic cardiovascular risk of coexisting hypertension and diabetes, emphasizing blood pressure reduction as a primary therapeutic target.
HTN and diabetes mellitus are 'silent killers' with rising global prevalence. The development of HTN and diabetes mellitus tracks each other over time. The coexistence of both clinical entities synergistically contributes to micro- and macro-vasculopathy along with cardiovascular and all-cause mortality. Various shared mechanisms underlie the pathophysiological relationship between HTN and diabetes mellitus. Moreover, BP reduction with lifestyle interventions and antihypertensive agents is a primary target for reducing cardiovascular risk among patients with HTN and diabetes mellitus.
No takes yet. Share an insight, caveat, or question.
Yildiz et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: